Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - GROSS PROFIT
Gross Profit SGMO - Sangamo Therapeutics, Inc.
-45.3 M
LAST VALUE
-20.32%
2 YEAR CAGR
-8.31%
5 YEAR CAGR
-13.44%
10 YEAR CAGR